TY - JOUR
T1 - The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization
AU - Banerjee, Subhash
AU - Sarode, Karan
AU - Vinas, Ariel
AU - Banerjee, Avantika
AU - Mohammad, Atif
AU - Brilakis, Emmanouil S.
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/8/24
Y1 - 2015/8/24
N2 - Eligible patients with symptomatic PAD or with a history of peripheral artery revascularization should be prescribed antiplatelet monotherapy for secondary prevention of both cardiovascular and limb events, using aspirin, clopidogrel, and/or vorapaxar. Given the significant overlap of PAD and coronary artery disease, the evidence presented in this article may have important implications for management of patients with coronary artery disease.
AB - Eligible patients with symptomatic PAD or with a history of peripheral artery revascularization should be prescribed antiplatelet monotherapy for secondary prevention of both cardiovascular and limb events, using aspirin, clopidogrel, and/or vorapaxar. Given the significant overlap of PAD and coronary artery disease, the evidence presented in this article may have important implications for management of patients with coronary artery disease.
KW - Antiplatelet therapy
KW - Endovascular revascularization
KW - Peripheral artery disease
UR - http://www.scopus.com/inward/record.url?scp=84942566937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942566937&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000208
DO - 10.1097/HCO.0000000000000208
M3 - Review article
C2 - 26241710
AN - SCOPUS:84942566937
SN - 0268-4705
VL - 30
SP - 525
EP - 535
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 5
ER -